The University of Chicago Header Logo

Connection

Richard A. Larson to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Neoadjuvant Therapy.
Richard A. Larson
Connection Strength
0.025
Neoadjuvant Therapy
  1. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Blood. 2014 Feb 27; 123(9):1353-60.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.